
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The role of m6A modification in the biological functions and diseases
Xiulin Jiang, Baiyang Liu, Zhi Nie, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 1400
Xiulin Jiang, Baiyang Liu, Zhi Nie, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 1400
Showing 1-25 of 1400 citing articles:
Cisplatin nephrotoxicity: new insights and therapeutic implications
Chengyuan Tang, Man J. Livingston, Robert L. Safirstein, et al.
Nature Reviews Nephrology (2022) Vol. 19, Iss. 1, pp. 53-72
Closed Access | Times Cited: 270
Chengyuan Tang, Man J. Livingston, Robert L. Safirstein, et al.
Nature Reviews Nephrology (2022) Vol. 19, Iss. 1, pp. 53-72
Closed Access | Times Cited: 270
m6A modification: recent advances, anticancer targeted drug discovery and beyond
Lijuan Deng, Wei-Qing Deng, Shu-Ran Fan, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 261
Lijuan Deng, Wei-Qing Deng, Shu-Ran Fan, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 261
RNA modifications: importance in immune cell biology and related diseases
Lian Cui, Rui Ma, Jiangluyi Cai, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 200
Lian Cui, Rui Ma, Jiangluyi Cai, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 200
N6-methyladenosine modification regulates ferroptosis through autophagy signaling pathway in hepatic stellate cells
Min Shen, Yujia Li, Yingqian Wang, et al.
Redox Biology (2021) Vol. 47, pp. 102151-102151
Open Access | Times Cited: 181
Min Shen, Yujia Li, Yingqian Wang, et al.
Redox Biology (2021) Vol. 47, pp. 102151-102151
Open Access | Times Cited: 181
Targeting the RNA m6A modification for cancer immunotherapy
Xinxin Li, Shoubao Ma, Youcai Deng, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 151
Xinxin Li, Shoubao Ma, Youcai Deng, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 151
Role of m6A writers, erasers and readers in cancer
Zhen Fang, Wentong Mei, Chang Qu, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 148
Zhen Fang, Wentong Mei, Chang Qu, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 148
Molecular mechanisms of environmental exposures and human disease
Haotian Wu, C. Eckhardt, Andrea Baccarelli
Nature Reviews Genetics (2023) Vol. 24, Iss. 5, pp. 332-344
Open Access | Times Cited: 126
Haotian Wu, C. Eckhardt, Andrea Baccarelli
Nature Reviews Genetics (2023) Vol. 24, Iss. 5, pp. 332-344
Open Access | Times Cited: 126
METTL3 promotes chemoresistance in small cell lung cancer by inducing mitophagy
Yueqin Sun, Weitao Shen, Shulu Hu, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 125
Yueqin Sun, Weitao Shen, Shulu Hu, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 125
scDART-seq reveals distinct m6A signatures and mRNA methylation heterogeneity in single cells
Matthew Tegowski, Mathieu N. Flamand, Kate D. Meyer
Molecular Cell (2022) Vol. 82, Iss. 4, pp. 868-878.e10
Open Access | Times Cited: 123
Matthew Tegowski, Mathieu N. Flamand, Kate D. Meyer
Molecular Cell (2022) Vol. 82, Iss. 4, pp. 868-878.e10
Open Access | Times Cited: 123
Mettl14 mediates the inflammatory response of macrophages in atherosclerosis through the NF-κB/IL-6 signaling pathway
Zheng Yang, Yunqi Li, Xianwen Ran, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 6
Open Access | Times Cited: 115
Zheng Yang, Yunqi Li, Xianwen Ran, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 6
Open Access | Times Cited: 115
RNA m6A demethylase FTO-mediated epigenetic up-regulation of LINC00022 promotes tumorigenesis in esophageal squamous cell carcinoma
Yuanbo Cui, Chunyan Zhang, Shanshan Ma, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 112
Yuanbo Cui, Chunyan Zhang, Shanshan Ma, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 112
Transcriptome-wide profiling and quantification of N6-methyladenosine by enzyme-assisted adenosine deamination
Yu‐Lan Xiao, Shun Liu, Ruiqi Ge, et al.
Nature Biotechnology (2023) Vol. 41, Iss. 7, pp. 993-1003
Open Access | Times Cited: 109
Yu‐Lan Xiao, Shun Liu, Ruiqi Ge, et al.
Nature Biotechnology (2023) Vol. 41, Iss. 7, pp. 993-1003
Open Access | Times Cited: 109
Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms
Fei Li, Zaosong Zheng, Wei Chen, et al.
Drug Resistance Updates (2023) Vol. 68, pp. 100938-100938
Closed Access | Times Cited: 104
Fei Li, Zaosong Zheng, Wei Chen, et al.
Drug Resistance Updates (2023) Vol. 68, pp. 100938-100938
Closed Access | Times Cited: 104
RNA-binding proteins and cancer metastasis
Shengjie Wang, Zelong Sun, Zhe Lei, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 748-768
Closed Access | Times Cited: 103
Shengjie Wang, Zelong Sun, Zhe Lei, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 748-768
Closed Access | Times Cited: 103
The roles and mechanism of m6A RNA methylation regulators in cancer immunity
Lu Chen, Ying He, Jinyu Zhu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114839-114839
Open Access | Times Cited: 102
Lu Chen, Ying He, Jinyu Zhu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114839-114839
Open Access | Times Cited: 102
Long non-coding RNA and RNA-binding protein interactions in cancer: Experimental and machine learning approaches
Hibah Shaath, Radhakrishnan Vishnubalaji, Ramesh Elango, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 325-345
Open Access | Times Cited: 95
Hibah Shaath, Radhakrishnan Vishnubalaji, Ramesh Elango, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 325-345
Open Access | Times Cited: 95
Methylation of GPRC5A promotes liver metastasis and docetaxel resistance through activating mTOR signaling pathway in triple negative breast cancer
Xueqi Ou, Yeru Tan, Jindong Xie, et al.
Drug Resistance Updates (2024) Vol. 73, pp. 101063-101063
Open Access | Times Cited: 85
Xueqi Ou, Yeru Tan, Jindong Xie, et al.
Drug Resistance Updates (2024) Vol. 73, pp. 101063-101063
Open Access | Times Cited: 85
Epigenetic modification of m6A regulator proteins in cancer
Yumin Wang, Yan Wang, Harsh Patel, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 83
Yumin Wang, Yan Wang, Harsh Patel, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 83
FTO Prevents Thyroid Cancer Progression by SLC7A11 m6A Methylation in a Ferroptosis-Dependent Manner
Feihong Ji, Xing-Hao Fu, Guoquan Li, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 81
Feihong Ji, Xing-Hao Fu, Guoquan Li, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 81
The RNA m6A writer WTAP in diseases: structure, roles, and mechanisms
Qibo Huang, Jie Mo, Zhibin Liao, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 10
Open Access | Times Cited: 77
Qibo Huang, Jie Mo, Zhibin Liao, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 10
Open Access | Times Cited: 77
Anti-HIV Drug Elvitegravir Suppresses Cancer Metastasis via Increased Proteasomal Degradation of m6A Methyltransferase METTL3
Long Liao, Yan He, Shu-Jun Li, et al.
Cancer Research (2022) Vol. 82, Iss. 13, pp. 2444-2457
Open Access | Times Cited: 75
Long Liao, Yan He, Shu-Jun Li, et al.
Cancer Research (2022) Vol. 82, Iss. 13, pp. 2444-2457
Open Access | Times Cited: 75
Inhibition of ALKBH5 attenuates I/R-induced renal injury in male mice by promoting Ccl28 m6A modification and increasing Treg recruitment
Juntao Chen, Cuidi Xu, Kun Yang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 73
Juntao Chen, Cuidi Xu, Kun Yang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 73
Systematic comparison of tools used for m6A mapping from nanopore direct RNA sequencing
Zhen-Dong Zhong, Ying-Yuan Xie, Hong-Xuan Chen, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 69
Zhen-Dong Zhong, Ying-Yuan Xie, Hong-Xuan Chen, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 69
Targeting N6-methyladenosine reader YTHDF1 with siRNA boosts antitumor immunity in NASH-HCC by inhibiting EZH2-IL-6 axis
Lina Wang, Lefan Zhu, Cong Liang, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 5, pp. 1185-1200
Open Access | Times Cited: 62
Lina Wang, Lefan Zhu, Cong Liang, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 5, pp. 1185-1200
Open Access | Times Cited: 62
scm6A-seq reveals single-cell landscapes of the dynamic m6A during oocyte maturation and early embryonic development
Huan Yao, Chun‐Chun Gao, Danru Zhang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 61
Huan Yao, Chun‐Chun Gao, Danru Zhang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 61